# JSK Therapeutics, Inc. — Form D

JSK Therapeutics, Inc. of SANDY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-12. The offering totals $1.0M, of which $963K was reported sold. Industry: Other Technology.

## Offering

- Filed: 2017-12-12
- Form: D
- Accession: 0001724999-17-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $963K
- Remaining: $50K
- Investors: 10
- Date of first sale: 2017-11-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-300466

## Issuer

- Name: JSK Therapeutics, Inc.
- CIK: 0001724999
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9758 CERVANTES CIRCLE, SANDY, UT, 84092
- Phone: 801-971-6678

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Dr. Joseph Nowoslawski | Director | Sandy, UT |
| Jason Ockey | Director | Salt Lake City, UT |
| DINESH PATEL | Director | Bothell, WA |
| Randall Peterson | Director | Sandy, UT |
| Paul Shami | Director | Sandy, UT |
| Dr. Joseph Nowoslawski | Executive Officer | Sandy, UT |
| Paul Shami | Executive Officer | Sandy, UT |

## More

- [CIK 1724999 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1724999&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001724999-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.